Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Yakugaku Zasshi ; 143(2): 183-189, 2023.
Artigo em Japonês | MEDLINE | ID: mdl-36724931

RESUMO

Opioid-induced constipation (OIC), an adverse event that occurs due to opioid analgesics, reportedly causes poor quality of life and adherence to opioid analgesics in patients. Therefore, this issue must be addressed appropriately. Naldemedine (NAL), a peripherally-acting µ-opioid receptor antagonist, is currently recommended for treating OIC when other laxatives are ineffective, but there have been no clinical reports of NAL being used prophylactically for OIC. Therefore, we conducted a retrospective survey of hospitalized patients who received NAL as prophylaxis for OIC with strong opioid analgesics to clarify the reality of this situation and to consider points to be taken into account in its clinical implementation. In this study, 61.7% of the subjects had an Eastern Cooperative Oncology Group performance status score of 3 or higher. The rate of addition of new laxatives and increased laxatives during seven days of NAL prophylaxis was 46.8%, and the rate of diarrhea was 6.1%. This study suggests that patients initiated with strong opioid analgesics during hospitalization often presented with poor performance status, and it is important to pay attention to constipation even under NAL prophylaxis. However, the incidence of diarrhea was low, and the safety of NAL prophylaxis was considered to be good.


Assuntos
Analgésicos Opioides , Constipação Induzida por Opioides , Humanos , Analgésicos Opioides/efeitos adversos , Constipação Induzida por Opioides/tratamento farmacológico , Laxantes/uso terapêutico , Qualidade de Vida , Estudos Retrospectivos , Constipação Intestinal/induzido quimicamente , Constipação Intestinal/prevenção & controle , Constipação Intestinal/tratamento farmacológico , Antagonistas de Entorpecentes/farmacologia , Antagonistas de Entorpecentes/uso terapêutico , Diarreia/induzido quimicamente
2.
Helicobacter ; 26(4): e12814, 2021 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-33977610

RESUMO

BACKGROUND: Non-Helicobacter pylori Helicobacter (NHPH) is not widely recognized as a cause of acute gastric mucosal lesions (AGML), as only a few cases of AGML caused by NHPH have been reported. We present here one case and examine the species and eradication of NHPH together with the three previously reported cases. CASE PRESENTATION: A 52-year-old woman presented with a two-day history of severe epigastric pain, nausea, and vomiting. An esophagogastroduodenoscopy showed mucosal edema, multiple erosions, and ulcerations in the antrum. Biopsy specimens taken from the antrum revealed long spiral-shaped organisms, suggesting NHPH. As both serum anti-Helicobacter pylori (H. pylori) antibody and H. pylori stool antigen test were negative, this case was diagnosed as AGML caused by NHPH. After the administration of esomeprazole 20 mg for 14 days and the interval of the following 12 days, AGML was deemed to have been cured endoscopically. In addition, microscopic examination and PCR analysis confirmed the success of NHPH eradication. CONCLUSIONS: NHPH should be considered a probable cause of AGML in cases that are not attributed to the other causes already recognized. Taking probability of spontaneous eradication into consideration, it is appropriate to start eradication therapy after confirming the chronicity of NHPH infection.


Assuntos
Gastrite , Infecções por Helicobacter , Helicobacter , Doença Aguda , Esomeprazol , Feminino , Mucosa Gástrica , Gastrite/diagnóstico , Gastrite/tratamento farmacológico , Infecções por Helicobacter/diagnóstico , Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori , Humanos , Pessoa de Meia-Idade
3.
Helicobacter ; 26(4): e12811, 2021 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-33908121

RESUMO

BACKGROUND AND AIM: There are only a few reports of non-Helicobacter pylori Helicobacter (NHPH) gastritis in Japanese patients. We aimed to examine its prevalence, clinical features, and esophagogastroduodenoscopy (EGD) findings based on 50 patients encountered in one facility. MATERIALS AND METHODS: Subjects were all patients who had undergone gastric mucosal biopsy endoscopically at Kenwakai Hospital for approximately 10 years. NHPH infection was diagnosed by microscopic findings of Giemsa staining performed on all specimens. PCR analysis of urease genes was performed to detect and identify NHPH, when informed consent was obtained. Helicobacter pylori-diagnostic tests were also performed. NHPH-infected patients were questioned about symptoms and animal contact. RESULTS: NHPH gastritis was found in 50 of 3847 patients (1.30%). The percentage increased to 3.35% (30 of 896 patients) in the latter 2 years and 4 months with increasing recognition of its characteristic endoscopic findings by endoscopists. PCR analysis, performed in 30 patients, detected NHPH in 28 patients: 26 as Helicobacter suis and 2 as Helicobacter heilmanii/Helicobacter ailurogastricus. Helicobacter pylori-diagnostic tests were almost negative. However, anti-H. pylori antibody showed high-negative titer (3.0-9.9 U/ml) in 12. Of 50 patients (consisting of 49 men and 1 woman), almost all were asymptomatic, and 25 were keeping pets. Regarding EGD findings, in all 50 patients, "crack-like mucosa" and/or nodular gastritis was noted in gastric antrum, and regular arrangement of collecting venules (RAC) was noted in gastric corpus. None of the patients infected with NHPH were co-infected with H. pylori. CONCLUSIONS: The prevalence was finally estimated to be approximately 3.35%. Helicobacter suis was the most common NHPH species. "Crack-like mucosa" and/or nodular gastritis in gastric antrum, RAC in gastric corpus, and H. pylori-negativity by H. pylori-diagnostic tests especially containing a high-negative titer of anti-H. pylori antibody may indicate NHPH infection.


Assuntos
Infecções por Helicobacter , Helicobacter pylori , Animais , Feminino , Mucosa Gástrica , Gastroscopia , Helicobacter , Infecções por Helicobacter/diagnóstico , Infecções por Helicobacter/epidemiologia , Helicobacter pylori/genética , Humanos , Japão/epidemiologia , Masculino , Prevalência
4.
Z Naturforsch C J Biosci ; 76(1-2): 21-25, 2021 Jan 27.
Artigo em Inglês | MEDLINE | ID: mdl-33119545

RESUMO

Natural compound tetrandrine was reported to inhibit the proliferation of T cells by inhibiting activation of NF-κB. Chemically, isotetrandrine differs from tetrandrine only in the stereochemistry at the chiral centers. The present study aimed to compare their anti-proliferation effects on human T cells with a focus on NF-κB. The IC50 values of tetrandrine against MOLT-4 cells, MOLT-4/DNR cells, and concanavalin A-activated peripheral blood mononuclear cells of healthy subjects and dialysis patients were 4.43 ± 0.22, 3.62 ± 0.22, 1.91 ± 0.22 and 3.03 ± 0.28 µM, respectively. Whereas, the IC50 values of isotetrandrine against the above immune cells were 2.19 ± 0.27, 2.28 ± 0.33, 1.29 ± 0.14 and 1.55 ± 0.26 µM, respectively. The inhibitory effect of isotetrandrine against the proliferation of T cells was stronger than that of tetrandrine significantly (p < 0.05). Molecular mechanism investigation showed that 10 µM of isotetrandrine largely decreased the expression of p-NF-κB and NF-κB in both MOLT-4 and MOLT-4/DNR T cells (p < 0.05), whereas 10 µM of tetrandrine slightly inhibited the phosphorylation of p-NF-κB with little influence on the expression of NF-κB. Taken together, absolute configurations of tetrandrine and isotetrandrine are suggested to influence on their anti-proliferation effects in human T cells via different regulation of NF-κB.


Assuntos
Benzilisoquinolinas/química , Proliferação de Células , Linfócitos T/efeitos dos fármacos , Benzilisoquinolinas/farmacologia , Linhagem Celular Tumoral , Humanos , NF-kappa B/metabolismo , Relação Estrutura-Atividade , Linfócitos T/metabolismo , Linfócitos T/fisiologia
5.
Gan To Kagaku Ryoho ; 47(10): 1477-1480, 2020 Oct.
Artigo em Japonês | MEDLINE | ID: mdl-33130744

RESUMO

The patient was a 56-year-old woman. A modified LSG15(VCAP-AMP-VECP)regimen was initiated as the first-line treatment for acute adult T-cell leukemia/lymphoma. On day 13 from the initiation of the second course of chemotherapy, the onset of hand-foot syndrome(HFS)(hands: Grade 2; feet: Grade 1)occurred. Therefore, the administration of a heparin analog cream and betamethasone butyrate propionate ointment was initiated. On day 20 from the start of the second course of chemotherapy, the foot symptoms improved; however, hand symptoms deteriorated to Grade 3. Frequent use of alcohol-based hand hygiene products is associated with infection prevention during neutropenia, but was likely an exacerbating factor. The symptoms gradually improved after this was taken into consideration, and the usage was discontinued. At the start of the third course, the symptoms had improved to Grade 1, and chemotherapy was continued. On day 11, symptoms worsened(Grade 2). HFS management was performed similar to that in the second course, and symptoms improved again.


Assuntos
Síndrome Mão-Pé , Leucemia-Linfoma de Células T do Adulto , Linfoma , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Carboplatina , Ciclofosfamida , Doxorrubicina , Etoposídeo , Feminino , Síndrome Mão-Pé/etiologia , Humanos , Leucemia-Linfoma de Células T do Adulto/tratamento farmacológico , Pessoa de Meia-Idade , Compostos de Nitrosoureia , Prednisolona , Vincristina , Vindesina
6.
Nihon Shokakibyo Gakkai Zasshi ; 115(1): 94-100, 2018.
Artigo em Japonês | MEDLINE | ID: mdl-29353856

RESUMO

An 80-year-old woman was brought to our hospital in an ambulance because of signs of peritoneal irritation. Computed tomography revealed volvulus, sigmoid colon dilation, and free air and pneumatosis within the colonic and bowel wall. An emergency laparotomy was performed after the diagnosis of colonic perforation associated with volvulus or pneumatosis. Numerous gas-filled cysts, up to 10mm in diameter, were located in the resected bowel wall. The cells at the inner lining of the cysts tested positive for D2-40 immunoreactivity, seemingly originating from the lymphatic vessels. In many cysts, KP-1 positive small mononuclear cells and/or foreign-body-type giant cells adhered to the D2-40 positive cells were observed. Fibrosis and lymphoplasmacytic infiltration was observed around the cysts. Contrary to the influential mechanical cause theory, in the present case, pneumatosis may have preceded volvulus, occurring as an idiopathic disease. Therefore, the lymphatic vessels were hypothesized to be associated with the pathogenesis of PCI.


Assuntos
Doenças do Colo , Volvo Intestinal/diagnóstico , Vasos Linfáticos , Pneumatose Cistoide Intestinal/diagnóstico , Idoso de 80 Anos ou mais , Feminino , Humanos , Tomografia Computadorizada por Raios X
7.
Auris Nasus Larynx ; 37(5): 609-14, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20171818

RESUMO

OBJECTIVES: Among the 50 laryngeal cancer patients who received SCL-CHEP between 1997 and 2008, we experienced three patients with complete epiglottis prolapse, which obstructed the neoglottis. By defining this complication as "Inverted epiglottis" and presenting the clinical features, we intend to elucidate the mechanism, risk factors, and management of this complication. METHODS: Details of the clinical features are presented. We conducted the following analyses: (1) distance from anterior commissure to the upper resected end of the surgical specimen was grossly measured. (2) Based on the analysis of sagittal cut CT images, the level of vallecula was identified and compared with the level of hyoid bone. (3) Distance between hyoid bone and cricoid arch (cricohyoid gap) after SCL-CHEP was measured using sagittal cut CT images. RESULTS: Prolonged edema of the neoglottis and delayed stomal closure were the main symptoms. In patients with the vallecula lower than the hyoid bone, excessive resection of the epiglottic petiole (anterior commissure-upper edge>25 mm) might be a risk factor. CONCLUSIONS: We reported a post-SCL-CHEP complication "Inverted epiglottis". Extensive excision of the epiglottic petiole, patients with a low vallecula profile, and incorrect suturing of epiglottic petiole during pexis are the three factors most related. Inverted epiglottis was treatable and most of the laryngeal function could be retrieved.


Assuntos
Obstrução das Vias Respiratórias/etiologia , Obstrução das Vias Respiratórias/cirurgia , Carcinoma de Células Escamosas/cirurgia , Cartilagem Cricoide/cirurgia , Epiglote/cirurgia , Osso Hioide/cirurgia , Neoplasias Laríngeas/cirurgia , Laringectomia/efeitos adversos , Complicações Pós-Operatórias/etiologia , Complicações Pós-Operatórias/cirurgia , Idoso , Obstrução das Vias Respiratórias/diagnóstico , Carcinoma de Células Escamosas/patologia , Humanos , Neoplasias Laríngeas/patologia , Laringoscopia , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Complicações Pós-Operatórias/diagnóstico , Prolapso , Reoperação/métodos , Fatores de Risco , Técnicas de Sutura , Tomografia Computadorizada por Raios X , Traqueotomia/métodos
8.
Artigo em Inglês | MEDLINE | ID: mdl-19940534

RESUMO

OBJECTIVES: Supracricoid laryngectomy (SCL) is a reliable laryngeal preservation surgery. However, close surgical margins are often inevitable. Based on clinicopathological analyses of supracricoid laryngectomized specimens, we evaluated the evidence base supporting minimal margins. METHODS: The distance between tumor edge and resected margin was measured macro- and microscopically at the anterior, posterior, superior and inferior edges, using 50 surgical specimens. The margins were correlated with pathological T staging and the prognoses. RESULTS: The anterior and posterior margins were the shortest, and the superior margin was the longest. The inferior margin was the only edge at which a positive margin was encountered. Cancer extending 10 mm below the glottal free edge significantly decreased the inferior margin. CONCLUSIONS: The surgical potential of SCL with cricohyoidoepiglottopexy was confirmed to be able to cope with tumor extensions showing margins of a few millimeters at the anterior, posterior and superior ends. Accurate assessment and management at the inferior margin is the key to stable local control.


Assuntos
Carcinoma de Células Escamosas/patologia , Carcinoma de Células Escamosas/cirurgia , Neoplasias Laríngeas/patologia , Neoplasias Laríngeas/cirurgia , Laringectomia/métodos , Idoso , Cartilagem Cricoide/patologia , Cartilagem Cricoide/cirurgia , Epiglote/patologia , Epiglote/cirurgia , Medicina Baseada em Evidências , Feminino , Glote/patologia , Glote/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , Invasividade Neoplásica , Recidiva Local de Neoplasia/patologia , Recidiva Local de Neoplasia/prevenção & controle , Estadiamento de Neoplasias , Cartilagem Tireóidea/patologia , Cartilagem Tireóidea/cirurgia
9.
Nihon Jibiinkoka Gakkai Kaiho ; 112(7): 540-9, 2009 Jul.
Artigo em Japonês | MEDLINE | ID: mdl-19670796

RESUMO

An analysis of clinical data on 50 patients undergoing supracricoid laryngectomy (SCL) between 1997 and 2008 i.e., cricohyoidoepiglottopexy (CHEP) in 47 and cricohyoidopexy (CHP) in 3 cases showed that the number of SCL cases operated on within a year surpassed that of Total Laryngectomy after 2003. Selection criteria included performance status 0-1 and blood gas PO2>80 torr, especially in those patients over 70-years-old. Postoperative wound infection occurred in 16 patients (32%), with four requiring additional surgical intervention (two ruptured pexis and two chondritis induced by C3-C4 osteophytes). A history of radiotherapy and systemic complications, i.e., diabetes and renal failure, added to the risk of wound infection. Introducing a clinical pathway shortened hospitalization. Vocal function was achieved in 96% and swallowing function in 89% of patients. Five-year crude survival in CHEP was 69% and in TL 51%. Laryngeal preservation was 70%, increasing to 89% after the introduction of SCL. SCL-CHEP is thus indicated for unfavorable T2 (ASCO 2006), well-selected T3, T4, and rT1-4 (radiation failures). Effort should emphasize a good balance in prognosis and function in organ preservation for laryngeal cancer.


Assuntos
Laringectomia/métodos , Adolescente , Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias
10.
Nihon Shokakibyo Gakkai Zasshi ; 103(10): 1169-75, 2006 Oct.
Artigo em Japonês | MEDLINE | ID: mdl-17023761

RESUMO

A 76-year-old man presented with back discomfort and jaundice. CT and MRI of the abdomen revealed a mass in the common bile duct. Cytology of the bile juice obtained by percutaneous transhepatic cholangio-drainage revealed class V. The patient underwent laparotomy and pancreatoduodenectomy. Pathology showed a carcinoid tumor of the biliary tract, 14 x 10 mm in size. Grimelius staining demonstrated the presence of argyrophilic granules. On immunochemistry, the tumor stained positive for chromogranin A and synaptophysin. He had two liver metastases 8 months postoperatively.


Assuntos
Neoplasias dos Ductos Biliares/patologia , Ductos Biliares Extra-Hepáticos , Tumor Carcinoide/patologia , Idoso , Neoplasias dos Ductos Biliares/cirurgia , Tumor Carcinoide/cirurgia , Humanos , Masculino , Pancreaticoduodenectomia
11.
Comp Biochem Physiol B Biochem Mol Biol ; 140(4): 543-50, 2005 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15763509

RESUMO

To investigate effect of estradiol-17beta (E(2)) treatment in vivo on binding of eel hepatocytes to HDL, we developed hepatocytes binding assay. When hepatocytes were incubated with 200 times excess of eel HDL, the binding of hepatocytes to HDL precoated on wells was inhibited competitively. This indicates that eel hepatocytes bound specifically to HDL. E(2) treatment in vivo induced vitellogenin (VTG) synthesis. Hepatocytes prepared from the same E(2) treatment eel showed 3-fold higher ability of binding to HDL compared to hepatocytes prepared from ells without E(2) treatment. We also examined effects of E(2) and HDL on VTG induction in cultured hepatocytes. VTG, determined by enzyme-linked immunosorbent assay (ELISA), induction was about two-times higher in the presence of both 10(-5) M of E(2) and 400 microg of HDL than in the presence of 10(-5) M E(2) alone. At concentrations below 10(-6) M E(2), VTG was not induced in the presence or absence of HDL. By SDS-PAGE and immunoblotting, VTG was detected only in the presence of both 10(-5) M of E(2) and HDL. Our findings strongly support the idea that HDL correlates with vitellogenesis in eel liver.


Assuntos
Enguias/metabolismo , Lipoproteínas HDL/metabolismo , Vitelogeninas/metabolismo , Animais , Células Cultivadas , Eletroforese em Gel de Poliacrilamida , Ensaio de Imunoadsorção Enzimática , Estradiol/farmacologia , Hepatócitos/efeitos dos fármacos , Hepatócitos/metabolismo , Japão , Sensibilidade e Especificidade , Vitelogeninas/efeitos dos fármacos , Vitelogeninas/isolamento & purificação
12.
Bull Tokyo Dent Coll ; 43(3): 181-5, 2002 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12455237

RESUMO

This report describes the proliferation and the expression of Cbfa-1 in a rare case of peripheral osteo-chondroma arising from the mandibular oral mucosa of an edentulous alveolar ridge. Histologically, the lesion consisted of mesenchymal cells with either bone or cartilage tissue in the center. Almost all the tumor cells were reactive for PCNA, however, only the cells around the bone and cartilage tissues were reactive for Cbfa-1. These results suggest that both the bone and the cartilage tissues in this case were produced by mesenchymal cells that originated from the peripheral periosteum of the alveolar ridge. Furthermore, we have shown that immunohistochemical staining for PCNA and Cbfa-1 can be used to investigate lesions with bone or cartilage formation and to distinguish between those produced by osteogenic cells from those that are just reactive and produced by dystrophic calcification.


Assuntos
Neoplasias Mandibulares/patologia , Proteínas de Neoplasias , Osteocondroma/patologia , Fatores de Transcrição/biossíntese , Idoso , Processo Alveolar/patologia , Divisão Celular , Feminino , Humanos , Técnicas Imunoenzimáticas , Arcada Edêntula/complicações , Neoplasias Mandibulares/complicações , Neoplasias Mandibulares/metabolismo , Osteoblastos/patologia , Osteocondroma/complicações , Osteocondroma/metabolismo , Antígeno Nuclear de Célula em Proliferação/biossíntese
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA